Dechra sells up

Veterinary and animal pharmaceutical companyDechra Pharmaceuticals(DPH) has made a radical change to its business by selling off its veterinary services business to US-firm Patterson Companies Inc for £87.5m. The deal, which is subject to shareholder approval, will help the company to largely clear its £102m net debt and allow it to concentrate on its much higher margin pharmaceutical business.

To continue reading, register today

to enjoy limited access to the following:

  • Daily trading news
  • Funds coverage
  • Features on big investment themes
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now